Aligos Therapeutics sued by Janssen over breach of contract, IP ownership

Aligos Therapeutics, Inc.

Janssen Biopharma filed complaint in Superior Court of California, San Mateo County on March 26, 2022.
Alleges breach of contract by CEO Lawrence Blatt and President Leonid Beigelman, tortious interference by Aligos.
Janssen seeks declaratory judgment on IP ownership, injunctive relief, and monetary damages.
Company believes allegations are without merit and intends to defend vigorously.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.